Conditions: Rosacea Erythema
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 92
Healthy volunteers: no

Brief summary:
The purpose of the study is to evaluate the patient-reported outcomes (feedbacks of patients)of a new drug for the treatment of erythema of rosacea (central facial redness). The feedback of patients receiving the active drug will be compared to the feedback of patients receiving the placebo.

Detailed description:

Arms:
arm 1: Participants applied brimonidine tartrate 0.5% gel topically once daily for 8 days. arm 2: Participants applied brimonidine tartrate vehicle gel topically once daily for 8 days.

Interventions: intervention 1: Brimonidine tartrate was applied cutaneously once daily for 8 days. intervention 2: Brimonidine tartrate vehicle was applied cutaneously once daily for 8 days.
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: